Payoneer Global Inc. (PAYO)
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Investigation
03/08/2022
Initial Lawsuit
06/17/2022
Lawsuit Progression
08/16/2022
Did Yext, Inc. mislead investors regarding its response to COVID-19 related disruptions? Did the company tout the true nature of its financials to hide “poor sales execution and performance”?
This post is open for investors to gather facts, and findings and track their exposure to related lawsuits. We invite investors and shareholders to contribute to this investigation for their own benefit, add events to the factual timeline below and vote on events’ pertinence.
A lawsuit was subsequently filed. We will update this post as it unfolds
03/08/2022
Yext discloses its results for Q4 2022 and the fiscal year 2022, including revenue of $100.9 million, or +9%, and gross profit of $76.4 million, or +8% compared to Q4 2021.
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$5.37 | $5.92 | $-0.55 | -9.29% |
A Yext, Inc. investor filed a federal securities class action lawsuit on behalf of a class consisting of all persons and entities that purchased or otherwise acquired Yext securities between March 4, 2021, and March 8, 2022, both dates inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) Yext’s revenue and earnings were significantly deteriorating because of, inter alia, poor sales execution and performance, as well as COVID-19 related disruptions;
(ii) accordingly, Yext was unlikely to meet consensus estimates for its full-year fiscal 2022 financial results and fiscal 2023 outlook; and
(iii) as a result, the company’s public statements were materially false and misleading at all relevant times.
The lead plaintiff deadline has passed, we will update this page as the lawsuit progresses.
Last event retrieved on 09/24/2022.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.